Thus, we independently confirmed the prognostic value of ATP5B, a key subunit of mito-chondrial complex V. As such, elevated levels of ATP5B could possibly be used to identify breast cancer patients that might benefit from treatment with bedaquiline. This evidence concerns the gene ATP5F1B and breast cancer.